USP36 and ovarian cancer: Indeed, the cytotoxicity of cisplatin or olaparib against ovarian cancer cells OVCAR8 and PEO1 was increased after knock-down of USP36, as compared to Ctrl cells (Figure 7G, H, protein expression is shown in Supplementary Figure S7A, and Supplementary Figure S8A–C).